Research and Markets has announced the addition of the "Ophthalmology Drug Development Pipeline Review, 2016" report to their offering.
The report provides comprehensive information on the pipeline development landscape for glaucoma, age-related macular degeneration, diabetic retinopathy, diabetic macular edema and keratoconjunctivitis sicca (dry eye), from Discovery through to the Pre-Registration stage. This includes an analysis of products by stage of development, molecular target, mechanism of action (MoA), route of administration (RoA) and molecule type.
A list of all products in development is provided, including dormant and discontinued projects. Finally, the report provides an overview of key players involved in the development of products in this area, and outlines recent updates and press releases in the field.
Reasons to buy:
Key Topics Covered:
1. Tables & Figures
3. Therapeutics Development by Stage
4. Therapeutics under Development by Companies
5. Therapeutics under Investigation by Universities/Institutes
6. Pipeline Products Glance
7. Products under Development by Companies
8. Products under Investigation by Universities/Institutes
9. Companies Involved in Therapeutics Development
10. Therapeutics Assessment
11. Recent Pipeline Updates
12. Dormant Projects
13. Discontinued Products
14. Product Development Milestones
For more information about this report visit http://www.researchandmarkets.com/research/lp8qsv/ophthalmology
View source version on businesswire.com: http://www.businesswire.com/news/home/20161128005748/en/Business Wire
Last updated on: 28/11/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.